FAME Publish
Daily lifestyle magazine

Global Vasculitis Treatment Strategic Business Report 2022: 23 Players Featured Including AB Science, Astellas Pharma, AstraZeneca and Baxter International – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Vasculitis Treatment: Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.

The global market for Vasculitis Treatment estimated at US$418.3 Million in the year 2020, is projected to reach a revised size of US$567.3 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.

Biologics, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$301.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Corticosteroids segment is readjusted to a revised 3.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $121.3 Million, While China is Forecast to Grow at 4% CAGR

The Vasculitis Treatment market in the U.S. is estimated at US$121.3 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$99.6 Million by the year 2027 trailing a CAGR of 4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Immunosuppressants Segment to Record 3.9% CAGR

In the global Immunosuppressants segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$73.9 Million in the year 2020 will reach a projected size of US$97.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 23 Featured) –

  • AB Science SA
  • Ablynx NV
  • Acorda Therapeutics, Inc.
  • Antares Pharma, Inc.
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Can-Fite BioPharma Ltd.
  • Celgene Corporation
  • Celltrion Healthcare Co., Ltd.
  • Coherus BioSciences
  • Daiichi Sankyo Co., Ltd.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Hospira, Inc.
  • Idera Pharmaceuticals, Inc.
  • Immunomedics, Inc.
  • Incyte Corporation
  • Lexicon Pharmaceuticals, Inc.
  • MedImmune LLC
  • Merck & Co., Inc.
  • Morphotek, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Regeneron Pharmaceuticals, Inc.
  • Sandoz International GmbH
  • Sanofi SA
  • Takeda Pharmaceutical Co., Ltd.
  • UCB SA
  • Vertex Pharmaceuticals Inc.

What’s New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies – Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Vasculitis Treatment – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/toe7jq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

-After Content-

Comments are closed.